Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination

BACKGROUND/PURPOSE: Vogt-Koyanagi-Harada (VKH) disease is a primary stromal choroiditis with bilateral granulomatous panuveitis. If initial-onset VKH is treated early and relentlessly the disease can be controlled and even “cured” in a substantial number of cases. We are reporting on a patient treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Papasavvas, Ioannis, Herbort, Carl P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256412/
https://www.ncbi.nlm.nih.gov/pubmed/34224024
http://dx.doi.org/10.1186/s12348-021-00251-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256412/
https://www.ncbi.nlm.nih.gov/pubmed/34224024
http://dx.doi.org/10.1186/s12348-021-00251-5

Ejemplares similares